Etiologic influence on chromosomal aberrations in European hepatocellular carcinoma identified by CGH

Pathology Research and Practice

Volumn 209, Issue 6, 2013, Pages 380-387

  Homayounfar, Kia ^a   Schwarz, Alexandra ^a   Enders, Christina ^a   Cameron, Silke ^a   Baumhoer, Daniel ^b   Ramadori, Giuliano ^a   Lorf, Thomas ^a   Gunawan, Bastian ^a   Sander, Bjoern ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Comparative genomic hybridization; Hepatocellular carcinoma; Liver cirrhosis etiology

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER PROGNOSIS; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 4P; CHROMOSOME 4Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE FREE SURVIVAL; EUROPE; FEMALE; GENETIC ASSOCIATION; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; SURVIVAL TIME;

EID: 84878391245     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.04.004     Document Type: Article

References (25)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA. Cancer J. Clin. 2005, 55:74-108.
2. Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002, 31:339-346.
3. Kuper H., Ye W., Broomé U., et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 2001, 34:714-718.
4. Kallioniemi A., Kallioniemi O.P., Sudar D., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821.
5. Moinzadeh P., Breuhahn K., Stützer H., et al. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology, and histological grade - results of an explorative CGH meta-analysis. Br. J. Cancer 2005, 92:935-941.
6. Zondervan P.E., Wink J., Alers J.C., et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J. Pathol. 2000, 192:207-215.
7. Guan X.Y., Fang Y., Sham J.S.T., et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes. Chromosomes Cancer 2000, 29:110-116.
8. Tornillo L., Carafa V., Richter J., et al. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J. Pathol. 2000, 192:307-312.
9. Raidl M., Pirker C., Schulte-Hermann R., et al. Multiple chromosomal abnormalities in human liver (pre)neoplasia. J. Hepatol. 2004, 40:660-668.
10. International Union Against Cancer: TNM Classification of Malignant Tumors 2009, Wiley-Blackwell, West Sussex, UK. 7th ed. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind (Eds.).
11. Kallioniemi O.P., Kallioniemi A., Piper J., et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes. Chromosomes Cancer 1994, 10:231-243.
12. Ihaka R., Gentleman R.R. A language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5:299-314.
13. Su C.W., Lei H.J., Chau G.Y., Hung H.H., Wu J.C., Hsia C.Y., Lui W.Y., Su Y.H., Wu C.W., Lee S.D. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch. Surg. 2012, 147:137-144.
14. Witjes C.D., Karim-Kos H.E., Visser O., van den Akker S.A., de Vries E., Ijzermans J.N., de Man R.A., Coebergh J.W., Verhoef C. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival. Eur. J. Gastroenterol. Hepatol. 2012, 24:450-457.
15. Koo S.H., Ihm C.H., Kwon K.C., et al. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet. Cytogenet. 2001, 130:22-28.
16. Marchio A., Mebbeb M., Pineau I., et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes. Chromosomes Cancer 1997, 18:59-65.
17. Marchio A., Pineau P., Meddeb M., et al. Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene 2000, 19:3733-3738.
18. Farazi P.A., DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 2006, 6:674-687.
19. Bozorgzadeh A., Orloff M., Abt P., Tsoulfas G., Younan D., Kashyap R., Jain A., Mantry P., Maliakkal B., Khorana A., Schwartz S. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl. 2007, 13:807-813.
20. Dejean A., Bougeleret L., Grzeschik K.H., et al. Hepatitis B virus DNA integration in a sequence homologous to v-erbA and steroid receptor genes in a hepatocellular carcinoma. Nature 1986, 322:70-72.
21. Plagemann P.G.W. Hepatitis C virus. Arch. Virol 1991, 120:165-180.
22. Kew M.C., Hepatitis B. C viruses and hepatocellular carcinoma. Clin. Lab. Med. 1996, 16:395-406.
23. Seitz H.K., Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol. Chem. 2006, 387:349-360.
24. Schwartz M., Dvorchik I., Roayaie S., et al. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J. Hepatol. 2008, 49:581-588.
25. Laurent-Puig P., Legoix P., Bluteau O. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001, 120:1763-1773.